secwatch.observer — SEC 8-K summary
======================================

Issuer:     Limitless X Holdings Inc. (LIMX)
CIK:        0001803977
Form:       8-K
Filed at:   2022-05-13T23:59:59+00:00
Accession:  0001065949-22-000066
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 3.02, 5.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio Lab Naturals to acquire Limitless X in reverse merger; LXI shareholders to own ~90% of combined entity
--------------------------------------------------------------------------------

- Bio Lab Naturals will acquire all of Limitless X (health/wellness, beauty, CBD) via share exchange.
- LXI shareholders receive 97M BLAB common shares (plus 9M shares in 6 months), owning ~90% of combined company.
- LXI CEO to purchase 500K shares of BLAB Series A Preferred Stock with super voting rights (60% votes), effecting change in control.
- Closing targeted for May 20, 2022; transaction subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1803977/000106594922000066/0001065949-22-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1803977/000106594922000066/blab8kmay132022.htm
  HTML page:      https://secwatch.observer/filing/0001065949-22-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer